Latest National Cancer Institute News

Ludwig Institute Scientific Director Chi Van Dang receives the 2024 AACR-Margaret Foti Award
Alzheimer’s may have once spread from person to person, but the risk of that happening today is incredibly low
Medicare turns 40: since 1984 our health needs have changed but the system hasn’t. 3 reforms to update it
New research finds half-cardio, half-strength training reduces cardiovascular disease risks
Method improves detection of potential therapeutic tumor targets in human biopsies
CAR T cell therapy for T cell lymphoma shows promise in phase I trial
Aggressive colon tumor may be vulnerable to cholesterol therapy
UW research finds that mailing HPV test kits directly to patients increases cervical cancer screening rates
Oral delivery possibility for silica-based C’Dots
A new theory linking evolution and physics has scientists baffled – but is it solving a problem that doesn’t exist?
The rise and fall of antibiotics. What would a post-antibiotic world look like?
New strategy attacks treatment-resistant lymphomas
Collective intelligence can help reduce medical misdiagnoses
Starpharma announces the presentation of DEP irinotecan combination data
Max Planck-Humboldt Research Award 2023
Severe Covid can alter long-term immune response
Mineralization of bone matrix regulates tumor cell growth
SALUD study examines health disparities for Latino survivors of childhood cancer
Ukraine blood cancer specialist helps Epworth patients
Long-range neuronal connections drive glioblastoma invasion
Ludwig Harvard team devises platform to bring “multiplex” imaging to the clinical pathology laboratory
Koselugo approved in China for paediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
Two Ludwig Cancer Research studies reveal essential role of neutrophils in immunotherapy
Cancer care and lessons learned from pandemic
Microcalcification ‘fingerprints’ can yield info about cancer
Simple low-dose aspirin may boost ovarian cancer survival
NIH grant to improve HIV-related cancer care abroad
Study helps explain severe graft-versus-host disease and potential solution
Ludwig Harvard imaging study reveals cellular, molecular and structural complexity of colorectal tumors
Just because someone had COVID before they had a heart attack doesn’t mean it was cause
Smoking linked to early vision loss and cataracts
Promising approach to mitigate complications of leukemia treatment
Koselugo approved in Japan for paediatric patients with plexiform neurofibromas in neurofibromatosis type1
Lynparza approved in China as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer
Researchers explore use of light-activated treatment to target wider variety of cancers
Lynparza approved in Japan as adjuvant treatment for patients with BRCA-mutated HER2-negative high-risk early breast cancer
Researchers identified markers of chemotherapy resistance and outcome in triple negative breast cancer
Scientists unlock potential for small cell lung cancer blood test
Portable cancer testing expands in sub-Saharan Africa
Stomach cancer paradigm shift
Lynparza approved in EU as adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer
Researchers uncover unanticipated aspects of genetic regulation of different brain tumors
CPTAC renews funding for proteogenomics research at Baylor
Lynparza recommended for approval in EU by CHMP as adjuvant treatment for patients with germline BRCA-mutated HER2-negative
Goldilocks treatment window could lead to cancer therapy without harmful side-effects
Bone loss medicines linked to lower ovarian cancer rates
Ludwig Princeton’s Eileen White named co-leader of $25 million Cancer Grand Challenges team tackling cancer cachexia
Schmitz receives $3.2 million to bring supportive cancer care to rural areas